ESAB Corporation
NYSE:ESAB
122.35 (USD) • At close December 24, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 673.25 | 707.053 | 689.744 | 689.348 | 680.996 | 720.422 | 684 | 664.127 | 620.265 | 661.177 | 647.911 | 624.215 | 605.968 | 629.804 | 568.128 |
Cost of Revenue
| 419.46 | 444.468 | 442.494 | 446.497 | 431.282 | 456.499 | 436.611 | 439.738 | 410.927 | 433.705 | 423.58 | 411.413 | 398.973 | 411.413 | 368.333 |
Gross Profit
| 253.79 | 262.585 | 247.25 | 242.851 | 249.714 | 263.923 | 247.389 | 224.389 | 209.338 | 227.472 | 224.331 | 212.802 | 206.995 | 218.391 | 199.795 |
Gross Profit Ratio
| 0.377 | 0.371 | 0.358 | 0.352 | 0.367 | 0.366 | 0.362 | 0.338 | 0.337 | 0.344 | 0.346 | 0.341 | 0.342 | 0.347 | 0.352 |
Reseach & Development Expenses
| 0 | 9.7 | 10.1 | 10.7 | 9 | 9.5 | 9.6 | 8.9 | 8 | 9.6 | 9.5 | 10.8 | 9.1 | 10.3 | 9.5 |
General & Administrative Expenses
| 0 | 146.187 | 0 | 150.115 | 0 | 150.115 | 0 | 270.826 | 0 | 135.413 | 135.413 | 0 | 0 | 0 | 124.419 |
Selling & Marketing Expenses
| 0 | -17.43 | 0 | -28.05 | 0 | 0 | 0 | -1.532 | 0 | 1.532 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 145.9 | 128.757 | 124.573 | 122.065 | 145.439 | 150.115 | 147.282 | 139.343 | 121.668 | 136.945 | 135.413 | 120.382 | 124.104 | 132.702 | 124.419 |
Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.836 | 3.3 | 0 | 0 | 0 | 0 | 11.208 | 0 |
Operating Expenses
| 145.9 | 138.457 | 134.673 | 132.765 | 145.439 | 150.115 | 147.282 | 139.343 | 121.668 | 136.945 | 135.413 | 120.382 | 124.104 | 132.702 | 124.419 |
Operating Income
| 106.015 | 124.128 | 112.577 | 110.086 | 101.146 | 108.639 | 90.663 | 78.579 | 80.994 | 85.878 | 83.614 | 73.049 | 78.664 | 82.2 | 72.301 |
Operating Income Ratio
| 0.157 | 0.176 | 0.163 | 0.16 | 0.149 | 0.151 | 0.133 | 0.118 | 0.131 | 0.13 | 0.129 | 0.117 | 0.13 | 0.131 | 0.127 |
Total Other Income Expenses Net
| -16.894 | -20.713 | -31.17 | -32.611 | -23.631 | -18.819 | -19.51 | -12.598 | -8.865 | -7.907 | 0.556 | -10.021 | -4.031 | 8.327 | -2.55 |
Income Before Tax
| 89.121 | 103.415 | 81.407 | 77.475 | 80.644 | 89.82 | 71.153 | 65.981 | 72.129 | 77.971 | 84.17 | 73.967 | 78.873 | 93.722 | 72.526 |
Income Before Tax Ratio
| 0.132 | 0.146 | 0.118 | 0.112 | 0.118 | 0.125 | 0.104 | 0.099 | 0.116 | 0.118 | 0.13 | 0.118 | 0.13 | 0.149 | 0.128 |
Income Tax Expense
| 18.074 | 17.885 | 18.504 | 17.921 | 19.808 | 20.974 | 37.024 | 5.541 | 17.836 | 20.047 | 25.746 | 33.366 | 17.441 | 15.61 | 13.992 |
Net Income
| 68.24 | 82.907 | 59.951 | 50.239 | 57.57 | 65.573 | 31.903 | 60.707 | 52.354 | 55.249 | 55.437 | 39.431 | 60.614 | 77.407 | 57.658 |
Net Income Ratio
| 0.101 | 0.117 | 0.087 | 0.073 | 0.085 | 0.091 | 0.047 | 0.091 | 0.084 | 0.084 | 0.086 | 0.063 | 0.1 | 0.123 | 0.101 |
EPS
| 1.13 | 1.37 | 0.99 | 0.83 | 0.96 | 1.09 | 0.53 | 1.01 | 0.87 | 0.92 | 0.92 | 0.68 | 1.01 | 1.29 | 0.96 |
EPS Diluted
| 1.12 | 1.36 | 0.98 | 0.83 | 0.95 | 1.08 | 0.53 | 1.01 | 0.87 | 0.92 | 0.92 | 0.68 | 1.01 | 1.29 | 0.96 |
EBITDA
| 106.015 | 119.355 | 110.653 | 119.893 | 121.804 | 126.329 | 112.534 | 122.682 | 91.088 | 94.354 | 100.859 | 99.806 | 102.368 | 104.797 | 94.096 |
EBITDA Ratio
| 0.157 | 0.199 | 0.187 | 0.178 | 0.158 | 0.19 | 0.192 | 0.138 | 0.177 | 0.169 | 0.171 | 0.191 | 0.176 | 0.172 | 0.171 |